EPO therapy during acute kidney disease: To use or not to use, that is the question

American Journal of Kidney Diseases

Volumn 46, Issue 5, 2005, Pages 967-969

  Kraus, Edward ^a   Rabb, Hamid ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ACUTE KIDNEY FAILURE; ANEMIA; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONVALESCENCE; CRITICAL ILLNESS; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; GLOMERULUS FILTRATION RATE; HEMATOLOGIC DISEASE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY ISCHEMIA; LIVER DYSFUNCTION; NONHUMAN; RENAL PROTECTION; SURVIVAL; TRANSFUSION; TREATMENT OUTCOME; VASCULAR SURGERY;

ANEMIA; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN, RECOMBINANT; HUMANS; KIDNEY FAILURE, ACUTE; RESEARCH DESIGN; RETROSPECTIVE STUDIES; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 27144511465     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.08.022     Document Type: Editorial

References (9)

1. T. Nemoto, N. Yokota, W.F. Keane, H. Rabb Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure Kidney Int 59 2001 246 251
2. P.K. Chatterjee Pleiotropic renal actions of erythropoietin Lancet 365 2005 1890 1892
3. H.L. Corwin, A. Gettinger, R.G. Pearl Efficacy of recombinant human erythropoietin in critically ill patients JAMA 288 2002 2827 2835
4. J. Park, B.F. Gage, A. Vijayan Use of EPO in critically ill patients with acute renal failure requiring renal replacement therapy Am J Kidney Dis 46 2005 791 798
5. G. Eknoyan, N.W. Levin, J.W. Eschbach Continuous quality improvement DOQI becomes K/DOQI and is updated Am J Kidney Dis 37 2001 179 194
6. M. Leist, P. Ghezzi, G. Grasso Derivatives of erythropoietin that are tissue protective but not erythropoietic Science 305 2004 239 242
7. M. Campise, A. Mikhail, T. Quaschning, J. Snyder, A. Collins Impact of pre-transplant anaemia correction and erythropoietin resistance on long-term graft survival Nephrol Dial Transplant 20 suppl 8 2005 Sviii8 Sviii12
8. S. Piantadosi Clinical Trials A Methodologic Perspective 1997 Wiley New York, NY
9. A. Besarab, W.K. Bolton, J.K. Browne The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin N Engl J Med 339 1998 584 590